No Data
First Pharmaceutical: Report of Shanghai First Pharmaceutical Co., Ltd. Third Quarter 2024
Shanghai First Pharmaceutical Co., Ltd. Report for the Third Quarter of 2024
Shanghai First Pharmaceutical Co., Ltd. operating data announcement for the third quarter of 2024
Shanghai no.1 pharmacy (600833.SH) released its performance for the first three quarters, with a net income of 0.147 billion yuan, a year-on-year increase of 156.21%.
Shanghai No.1 Pharmacy (600833.SH) disclosed the third quarter report for 2024, achieving revenue of 13...
Shanghai No. 1 Pharmacy (600833.SH): The net income for the first three quarters was 0.147 billion yuan, a year-on-year increase of 156.21%.
Geili News October 30th | Shanghai No.1 Pharmacy (600833.SH) announced its third-quarter report, with revenue in the first three quarters of 1.369 billion yuan, a year-on-year increase of 2.48%, net income of 0.147 billion yuan, a year-on-year increase of 156.21%, non-net profit of 7.81 million yuan, a year-on-year decrease of 70.21%, and basic earnings per share of 0.6604 yuan.
Shanghai No. 1 Pharmacy (600833.SH): In the future, the company will continue to optimize and strengthen its business through strategies such as expanding encrypted outlets around the "15-minute life circle".
Shanghai No.1 Pharmacy (600833.SH) stated at the performance briefing on October 15 that in the future, the company will continue to optimize and strengthen its business by enhancing its professional service capabilities, reinforcing its supply chain foundation, improving logistics efficiency, increasing marketing promotions, rapidly expanding online channels, and filling gaps in the encrypted network based on the 'Fifteen-Minute Life Circle' expansion strategy.
No Data
No Data